|
Generic Name : Linagliptin
Pronunciation : LIN-a-GLIP-tin
Therapeutic Classification : Antidiabetics
ICD Code : Y42.3
Trade Name(s): International- Tradjenta. Why it is prescribed (Indications) : This medication is a dipeptidyl peptidase-4 (DPP-4) inhibitor, prescribed for type 2 diabetes. It increases insulin secretion by pancreas. When it is not to be taken (Contraindications): Contraindicated in patients with history of high blood ketone levels, type 1 diabetes, and hypersensitivity.
Dosage & When it is to be taken : PO- The recommended dose is 5 mg once daily. How it should be taken : It comes as a tablet to take by mouth, with or without food. Warnings and Precautions : * Caution should be exercised in patients with history of inflammation of the pancreas, using insulin, any allergy, who are taking other medications, during pregnancy and breastfeeding. * Follow the diet and exercise program as directed by your physician. * Monitor fasting blood glucose and hemoglobin A1c regularly while taking this medication. Side Effects : Stuffy or runny nose, sore throat, inflammation of pancreas and low blood sugar. * Avoid excess dosage. Storage Conditions : Store it at room temperature (20 to 25°C). |
![]() Comment & Contribute
![]()
![]() ![]() | ||



Ask an Expert